Increased pulse pressure is associated with left atrial enlargement in resistant hypertensive patients

References

• Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, . Resistant hypertension: Diagnosis, evaluation, and treatment. A Scientific Statement from the American Heart Association Professional Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403–1419.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Vaccarella A, Negri F, Sala C. Resistant hypertension and left ventricular hypertrophy: An overview. J Am Soc Hypertens. 2010;4:319–324.
   PubMed Web of Science ®Google Scholar
• Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET, . Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: The Strong Heart Study (SHS). Am Heart J. 2006;151:412–418.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation. 1995;92:835–841.
   PubMed Web of Science ®Google Scholar
• Piotrowski G, Banach M, Gerdts E, Mikhailidis DP, Hannam S, Gawor R, . Left atrial size in hypertension and stroke. J Hypertens. 2011;29:1988–1993.
   PubMedGoogle Scholar
• Verdecchia P, Reboldi GP, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, . Atrial fibrillation in hypertension, Predictors and outcome. Hypertension. 2003;41:218–223.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, . J, Prevention of atrial fibrillation: Report from a national heart, lung, and blood institute workshop. Circulation. 2009;119:606–618.
   PubMed Web of Science ®Google Scholar
• Pan NH, Tsao HM, Chang NC, Chen YJ, Chen SA. Aging dilates atrium and pulmonary veins: Implications for the genesis of atrial fibrillation. Chest. 2008;133:190–196.
   PubMedGoogle Scholar
• Strizke J, Markus MR, Duderstadt S, Lieb W, Luchner A, Döring A, . The aging process of the heart: Obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Ausgburg) study, J Am Coll Cardiol. 2009;54:1982–1989.
   PubMedGoogle Scholar
• Gottdiener JS, Reda DJ, Williams DW, Materson BJ. Left atrial size in hypertensive men: Influence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol. 1997;29:651–658.
   PubMed Web of Science ®Google Scholar
• Gerds E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, . Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002;39:739–743.
   PubMedGoogle Scholar
• Oliveras A, Armario P, Martell-Clarós N, Ruilope LM, de la Sierra A on behalf of the Spanish Society of Hypertension-Resistant Hypertension Registry. Urinary albumin excretion is associated with nocturnal systolic blood pressure in resistant hypertensives. Hypertension. 2011;57:556–560.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereus RB, Flasckampf FA, Foster E, Pellikka PA, . Recommendations for chamber quantification: A Report of the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a Brach of the European Society of Cardiology. Eur J Echocardiog. 2006;7:79–108.
   PubMed Web of Science ®Google Scholar
• Hernández del Rey R, Armario P, Martín-Baranera M, Sánchez P, Cárdenas G, Pardell H. Target organ damage and cardiovascular risk profile in resistant hypertension. Influence of white-coat effect. Blood Press Monit. 1998;3:331–337.
   PubMedGoogle Scholar
• Armario P, Oliveras A, Hernández del Rey R, Poch E, Larrouse M, Roca-Cusachs A, . Prevalence of target organ damage and factors associated with cardiovascular events in subjects with resistant hypertension. Med Clin (Barc). 2009;133:127–131 (Article in Spanish).
   PubMedGoogle Scholar
• Oliveras A, Armario P, Hernández-del Rey R, Arroyo JA, Poch E, Larrouse M, . Urinary albumin excretion is associated with true resistant hypertension. J Hum Hypertens. 2010;24: 27–33.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Vaccarella A, Negri F, Sala C. Resistant hypertension and left ventricular hypertrophy: An overview. J Am Soc Hypertens. 2010;4:319–324.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Sala C, . Prevalence and correlates of left atrial enlargement in essential hypertension: Role of ventricular geometry and the metabolic syndrome. J Hypertens. 2005;23:875–882.
   PubMed Web of Science ®Google Scholar
• Vaziri SM, Larson MG, Lauer MS, Benjamin EJ. Levy D. Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension. 1995;25:1155–1160.
   PubMed Web of Science ®Google Scholar
• Tedesco MA, Di Salvo G, Ratti G, Natale F, Iarussi D, Iacono A. Left atrial size in 164 hypertensive patients: An echocardiographic and ambulatory blood pressure study. Clin Cardiol. 2001;24:603–607.
   PubMedGoogle Scholar
• Cuspidi C, Meani S, Valerio C, Fusi V, Catini E, Sala C, . Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals. J Hypertens. 2005;23:1589–1595.
   PubMed Web of Science ®Google Scholar
• Staessen J A, Thijs L, O’Brien ET, Bulpìtt CJ, de Leeuw PW, Fagard RH, . for the Syst-Eur Trial Investigators.Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens. 2002;15;835–843.
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, . Pulse pressure and risk of new-onset atrial fibrillation. JAMA. 2007;297:709–715.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Lapenna D, Cuccurullo F. Risk of atrial fibrillation in dipper and nondipper sustained hypertensive subjects. Blood Press Monit. 2008;13:193–197.
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Andrikou I, Thomopoulos C, Syrseloudis D, Stergiou G, Stefanadis C. Increased nighttime blood pressure or nondipping profile for prediction of cardiovascular outcomes. J Hum Hypertens. 2011;25:281–293.
   PubMed Web of Science ®Google Scholar
• Muxfeldt ES, Salles GF. Pulse pressure or dipping pattern: Which one is a better cardiovascular risk marker in resistant hypertension? J Hypertens. 2008;26:878–884.
   PubMed Web of Science ®Google Scholar
• Triantafyllidi H, Ikonomidis I, Lekakis J, Panou F, Georgoula G, Fountoulaki K, . Pulse pressure determines left atrial enlargement in non-dipper patients with never-treated essential hypertension. J Hum Hypertens. 2007;21:897–899.
   PubMed Web of Science ®Google Scholar